ENDO INTERNATIONAL PLC (ENDP) Stock Price, Forecast & Analysis
USA - NASDAQ:ENDP - IE00BJ3V9050 - Common Stock
ENDP Key Statistics, Chart & Performance
The current stock price of ENDP is 0.2926 USD. In the past month the price decreased by -45.05%. In the past year, price decreased by -87.39%.
ENDP Latest News, Press Relases and Analysis
ENDP Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 42.1 | 876.24B | ||
| JNJ | JOHNSON & JOHNSON | 17.92 | 447.95B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 18.28 | 251.61B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 14.02 | 242.95B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 12.62 | 215.33B | ||
| MRK | MERCK & CO. INC. | 9.58 | 210.79B | ||
| PFE | PFIZER INC | 7.69 | 139.92B | ||
| SNY | SANOFI-ADR | 11.21 | 119.42B | ||
| GSK | GSK PLC-SPON ADR | 7.73 | 93.91B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 7.08 | 94.59B | ||
| ZTS | ZOETIS INC | 19 | 53.40B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 194.14 | 42.92B |
Related stock screener links
About ENDP
Company Profile
Endo International Plc operates as a pharmaceutical company, which engages in the development, manufacture, and distribution of branded and generic pharmaceutical products. The company is headquartered in Dublin, Dublin and currently employs 3,103 full-time employees. The company went IPO on 2014-03-03. The firm operates through four business segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals and International Pharmaceuticals. Its Branded Pharmaceuticals segment includes a variety of branded products in the areas of urology, orthopedics, endocrinology, medical aesthetics and bariatrics, among others. Its products include XIAFLEX, SUPPRELIN LA, NASCOBAL Nasal Spray, AVEED, QWO, PERCOCET, TESTOPEL, EDEX and LIDODERM, among others. Its Sterile Injectables segment consists of branded sterile injectable products such as VASOSTRICT, ADRENALIN and APLISOL, among others, and certain generic sterile injectable products, including ertapenem for injection and ephedrine sulfate injection. The firm's Generic Pharmaceuticals segment consists of a product portfolio, including solid oral extended-release, solid oral immediate-release, liquids, semi-solids, patches, powders, ophthalmic and sprays.
Company Info
ENDO INTERNATIONAL PLC
First Floor, Minerva House, Simmonscourt Road, Dublin 4
DUBLIN DUBLIN 19355 IE
CEO: Blaise Coleman
Employees: 3103
Phone: 35312682000.0
ENDO INTERNATIONAL PLC / ENDP FAQ
Can you describe the business of ENDO INTERNATIONAL PLC?
Endo International Plc operates as a pharmaceutical company, which engages in the development, manufacture, and distribution of branded and generic pharmaceutical products. The company is headquartered in Dublin, Dublin and currently employs 3,103 full-time employees. The company went IPO on 2014-03-03. The firm operates through four business segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals and International Pharmaceuticals. Its Branded Pharmaceuticals segment includes a variety of branded products in the areas of urology, orthopedics, endocrinology, medical aesthetics and bariatrics, among others. Its products include XIAFLEX, SUPPRELIN LA, NASCOBAL Nasal Spray, AVEED, QWO, PERCOCET, TESTOPEL, EDEX and LIDODERM, among others. Its Sterile Injectables segment consists of branded sterile injectable products such as VASOSTRICT, ADRENALIN and APLISOL, among others, and certain generic sterile injectable products, including ertapenem for injection and ephedrine sulfate injection. The firm's Generic Pharmaceuticals segment consists of a product portfolio, including solid oral extended-release, solid oral immediate-release, liquids, semi-solids, patches, powders, ophthalmic and sprays.
What is the current price of ENDP stock?
The current stock price of ENDP is 0.2926 USD. The price decreased by -5% in the last trading session.
What is the dividend status of ENDO INTERNATIONAL PLC?
ENDP does not pay a dividend.
What is the ChartMill rating of ENDO INTERNATIONAL PLC stock?
ENDP has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Can you provide the PE ratio for ENDP stock?
The PE ratio for ENDO INTERNATIONAL PLC (ENDP) is 0.13. This is based on the reported non-GAAP earnings per share of 2.33 and the current share price of 0.2926 USD.
What is the ownership structure of ENDO INTERNATIONAL PLC (ENDP)?
You can find the ownership structure of ENDO INTERNATIONAL PLC (ENDP) on the Ownership tab.
ENDP Technical Analysis
ENDP Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to ENDP. ENDP has a bad profitability rating. Also its financial health evaluation is rather negative.
ENDP Financial Highlights
Over the last trailing twelve months ENDP reported a non-GAAP Earnings per Share(EPS) of 2.33. The EPS decreased by -12.08% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -93.31% | ||
| ROA | -40.81% | ||
| ROE | N/A | ||
| Debt/Equity | -2.52 |
ENDP Forecast & Estimates
7 analysts have analysed ENDP and the average price target is 1.02 USD. This implies a price increase of 248.6% is expected in the next year compared to the current price of 0.2926.
For the next year, analysts expect an EPS growth of -57.56% and a revenue growth -18.43% for ENDP